Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.62 |
| ▸ | MMP2 | P08253 | 1/20 | 0.61 |
| ▸ | MMP7 | P09237 | 1/20 | 0.61 |
| ▸ | MMP9 | P14780 | 1/20 | 0.61 |
| ▸ | MMP12 | P39900 | 1/20 | 0.61 |
| ▸ | MMP13 | P45452 | 1/20 | 0.61 |
| ▸ | MME | P08473 | 3/20 | 0.61 |
| ▸ | CPA1 | P15085 | 1/20 | 0.57 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.57 |
| ▸ | CTSB | P07858 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycylleucylphenylalanine SCHEMBL4281369 | 1.00 | ACE (0.62) | ACEMMP2MMP7MMP9MMP12 | |
| SCHEMBL21192616 | 0.95 | ACE (0.57) | ACEMMP2MMP7MMP9MMP12 | |
| SCHEMBL21192611 | 0.95 | ACE (0.57) | ACEMMP2MMP7MMP9MMP12 | |
| SCHEMBL9551455 | 0.95 | MME (0.64) | ACEMMP2MMP7MMP9MMP12 | |
| SCHEMBL5370772 | 0.95 | MME (0.64) | ACEMMP2MMP7MMP9MMP12 | |
| SCHEMBL9829182 | 0.95 | MME (0.64) | ACEMMP2MMP7MMP9MMP12 | |
| SCHEMBL30396564 | 0.93 | ACE (0.63) | ACEMMP2MMP7MMP9MMP12 | |
| SCHEMBL8983297 | 0.92 | CTSB (0.62) | ACEMMP2MMP7MMP9MMP12 | |
| SCHEMBL8983313 | 0.92 | CTSB (0.62) | ACEMMP2MMP7MMP9MMP12 | |
| SCHEMBL29427560 | 0.92 | MME (0.58) | ACEMMP2MMP7MMP9MMP12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3227 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111051329-B | Hamiltelin derivatives and their antibody drug complexes | 住友制药株式会社 | 2024-07-30 | — | — | CN | claimed |
| CN-117230048-A | Threonine aldolase mutant with improved stereoselectivity and application thereof | 浙江工业大学 | 2023-12-15 | — | — | CN | claimed |
| US-11801307-B2 | Antibody-polymer-drug conjugates | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2023-10-31 | — | — | US | claimed |
| EP-4045087-A1 | POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND USING THEREOF | University of Utah Research Foundation (US) | 2022-08-24 | — | — | EP | claimed |
| US-20220249682-A1 | POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND USING THEREOF | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2022-08-11 | — | — | US | claimed |
| CN-107513103-B | MASP isoforms as inhibitors of complement activation | OMEROS CORP. (US) | 2026-05-26 | — | — | CN | disclosed |
| CN-106987570-B | Cas9 nuclease R780A and application thereof | SHANGHAI JIAO TONG UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-122080238-A | RBoNT recombinant protein and precursor thereof, and preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-114080232-B | Extracellular vesicles for vaccine delivery | Lhasa Sales Co.,Ltd. (CH) | 2026-05-26 | — | — | CN | disclosed |
| CN-116194479-B | Anti-TAU antibodies | GT创新公司 | 2026-05-22 | — | — | CN | disclosed |
| WO-2026107236-A1 | COMPOSITIONS AND METHODS FOR VACCINATION AGAINST MYCOBACTERIUM TUBERCULOSIS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| CN-106794263-B | Vaccine with antigen and interleukin-21 as adjuvant | 宾夕法尼亚大学理事会 | 2026-05-19 | — | — | CN | disclosed |
| CN-113969286-A | Rice cadmium low-accumulation molecular marker, mutant gene, detection kit, rapid identification method and application thereof, and typing primer | 湖南杂交水稻研究中心 | 2022-01-25 | — | — | CN | disclosed |
| CN-108138170-B | DEPDC 1-derived peptides and vaccines containing the same | 肿瘤疗法科学股份有限公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-113968911-A | insulin-Fc fusion protein and application thereof | 江苏晟斯生物制药有限公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-113969290-A | Deep sea bacterium-derived alpha-glucosidase QsGH97a and coding gene and application thereof | 中南大学 | 2022-01-25 | — | — | CN | disclosed |
| CN-107847592-B | Antibodies against human CSF-1R for inducing lymphocytosis in lymphomas or leukemias | 豪夫迈·罗氏有限公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113957061-A | Administration of kynurenine depleting enzymes for tumor therapy | 得克萨斯大学体系董事会 | 2022-01-21 | — | — | CN | disclosed |
| CN-113956361-A | Antibodies to ticagrelor and methods of use thereof | 免疫医疗有限公司 | 2022-01-21 | — | — | CN | disclosed |
| US-20090143279-A1 | Methods and compositions for treating metabolic disorders | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2009-06-04 | — | — | US | disclosed |